BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2427603)

  • 21. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
    Ashworth J; Kahan MC; Breathnach SM
    J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes.
    Basham TY; Nickoloff BJ; Merigan TC; Morhenn VB
    J Invest Dermatol; 1984 Aug; 83(2):88-90. PubMed ID: 6206165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal and neoplastic Langerhans cells: phenotypic comparison with other types of macrophages.
    Ralfkiaer E; Stein H; Ralfkiaer N; Hou-Jensen K; Mason DY
    Adv Exp Med Biol; 1985; 186():1009-15. PubMed ID: 3876694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC class II antigen expression in normal human epidermis.
    Carr MM; McVittie E; Guy K; Gawkrodger DJ; Hunter JA
    Immunology; 1986 Oct; 59(2):223-7. PubMed ID: 2429921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis.
    Dezutter-Dambuyant C; Cordier G; Schmitt D; Faure M; Laquoi C; Thivolet J
    Br J Dermatol; 1984 Jul; 111(1):1-11. PubMed ID: 6204670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATPase, antigens detected by monoclonal antibodies, ultrastructural characters: which is the best marker for Langerhans cells?
    De Panfilis G
    Arch Dermatol Res; 1983; 275(6):407-11. PubMed ID: 6229220
    [No Abstract]   [Full Text] [Related]  

  • 29. Ia antigens are expressed on ATPase-positive dendritic cells in chicken epidermis.
    Pérez Torres A; Millan Aldaco DA
    J Anat; 1994 Jun; 184 ( Pt 3)(Pt 3):591-6. PubMed ID: 7928646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral mucosal Langerhans cells express DR and DQ antigens.
    Walsh LJ; Seymour GJ; Savage NW
    J Dent Res; 1986 Mar; 65(3):390-3. PubMed ID: 3457041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of inflammatory cell phenotypes in human oral carcinomas by means of monoclonal antibodies.
    Löning T; Broemel H; Becker WM; Otto HF
    Arch Oral Biol; 1983; 28(12):1093-100. PubMed ID: 6607724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Langerhans cells in hypospadias: an analysis of Langerin (CD207) and HLA-DR on epidermal sheets and full thickness skin sections.
    Haid B; Reider D; Nägele F; Spinoit AF; Pechriggl E; Romani N; Fritsch H; Oswald J
    BMC Urol; 2019 Nov; 19(1):114. PubMed ID: 31718599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells.
    Verrier AC; Schmitt D; Staquet MJ
    Int Arch Allergy Immunol; 1999 Sep; 120(1):56-62. PubMed ID: 10529589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Class II MHC antigen (HLA-DR) expression in the developing sweat gland.
    Lampert IA; Easty D; Evans DJ
    Tissue Antigens; 1986 Nov; 28(5):269-74. PubMed ID: 2435016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Numerical, morphological and phenotypic changes in Langerhans cells in the course of murine graft-versus-host disease.
    Asagoe K; Takahashi K; Yoshino T; Kondo E; Tanaka R; Arata J; Akagi T
    Br J Dermatol; 2001 Dec; 145(6):918-27. PubMed ID: 11899145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistological characterization of lymphoid cell populations in the early human placental bed.
    Bulmer JN; Sunderland CA
    Immunology; 1984 Jun; 52(2):349-57. PubMed ID: 6376338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours.
    Löning T; Caselitz J; Seifert G; Weber K; Osborn M
    Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contact allergens, but not irritants, alter receptor-mediated endocytosis by human epidermal Langerhans cells.
    Rizova H; Carayon P; Barbier A; Lacheretz F; Dubertret L; Michel L
    Br J Dermatol; 1999 Feb; 140(2):200-9. PubMed ID: 10733267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enriched Langerhans cells express more HLA-DR determinants than blood-derived adherent cells (monocytes and dendritic cells).
    Bjercke S; Gaudernack G; Braathen LR
    Scand J Immunol; 1985 May; 21(5):489-92. PubMed ID: 2408326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human embryonic epidermis contains a diverse Langerhans cell precursor pool.
    Schuster C; Mildner M; Mairhofer M; Bauer W; Fiala C; Prior M; Eppel W; Kolbus A; Tschachler E; Stingl G; Elbe-Bürger A
    Development; 2014 Feb; 141(4):807-15. PubMed ID: 24496618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.